Melfalax is a prescription medication used to treat certain types of cancer, including:
- Multiple myeloma (a type of blood cancer)
- Plasmacytoma (a type of cancer that affects the bones)
- Lymphoma (a type of cancer that affects the immune system)
Composition:
Melfalax is a clear, colorless solution containing 50mg of melphalan per milliliter.
Mechanism of Action:
Melphalan works by:
- Interfering with the growth and reproduction of cancer cells
- Damaging the genetic material of cancer cells, making it difficult for them to grow and divide
Uses:
Melfalax is used to treat:
- Multiple myeloma (a type of blood cancer)
- Plasmacytoma (a type of cancer that affects the bones)
- Lymphoma (a type of cancer that affects the immune system)
Dosage:
The recommended dosage of Melfalax is:
- 50mg/m² body surface area administered intravenously over 15-30 minutes
- Repeat every 4-6 weeks, depending on the patient’s response to treatment
Side Effects:
Common side effects of Melfalax include:
- Nausea and vomiting
- Diarrhea
- Fatigue
- Headache
- Dizziness
- Increased risk of infection
- Increased risk of bleeding
Recommendation:
Melfalax is recommended for patients with multiple myeloma, plasmacytoma, or lymphoma who have not responded to other treatments. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.
Important Note:
Patients should not take Melfalax if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or lung problems, before taking Melfalax.
Some common brands of melphalan include:
- Alkeran (GlaxoSmithKline)
- Melphalan (Pfizer)
Please note that Melfalax is not available in all markets and may be approved for different indications and dosages in different regions.
Reviews
There are no reviews yet.